Genetic Dissection of the defect in the SLAM-receptor.........
SLAM 受体缺陷的基因剖析.........
基本信息
- 批准号:7135752
- 负责人:
- 金额:$ 26.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:antigen presentationbioengineering /biomedical engineeringbiological signal transductioncell surface receptorschromatingene deletion mutationgenetic recombinationgenetic screeninggenetic susceptibilitygenetic transcriptiongenetically modified animalsgenotypehelper T lymphocyteimmune tolerance /unresponsivenessimmunophenotypelaboratory mouseleukocyte activation /transformationmethod developmentsingle nucleotide polymorphismsystemic lupus erythematosustransfection
项目摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of
autoantibodies against a wide spectrum of self-antigens, especially from the cell nucleus. Genetic
predisposition is an important contributor to susceptibility to SLE in both humans and animals. Genes in
multiple pathways participate in mediating disease pathogenesis, and epistatic interactions amongst these
genes influence the severity of disease. One group includes genes whose products are active in
physiologic pathways of waste disposal mechanisms in the body, and includes genes involved in removal
of circulating immune complexes and apoptotic cells by the mononuclear phagocyte system. The second
group encodes genes that regulate thresholds for tolerance and activation of T and B lymphocytes.
This project is part of an interactive PPG, which seeks to address the overall hypothesis that mutations
in one or more of the seven SLAM-family genes affect pathways that contribute to tolerance to selfantigens
in humans and mice. Collectively, our observations made in humans and mice strongly support
this
Specifically we will:
Aim 1. test the hypothesis that the SLAM-Family-locus {CD244<->Ly108} governs CD4 T cell and antigen
presenting cell functions in the C57BL/6 mouse.
Aim 2.test the hypothesis that deletion of the {CD244<->Ly108} genomic interval causes loss of tolerance
toward chromatin in C57BL/6 mice.
Aim 3.test the hypothesis that SLAM-family genes derived from 129Sv mice contribute to the development
of lupus upon introduction into the {CD244<->Ly108}-/- C57BL/6 mouse.
Together these experiments should clarify the interplay between APC, T and B cells governed by the
SLAM-Family genes and their control of susceptibility to murine lupus. The results of these studies should
suggest therapeutic strategies that can be applied to SLE patients.
系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,其特征是产生
针对多种自身抗原(尤其是来自细胞核的自身抗原)的自身抗体。遗传
易感性是人类和动物患系统性红斑狼疮的重要因素。基因在
多种途径参与介导疾病发病机制,以及这些途径之间的上位相互作用
基因影响疾病的严重程度。一组包括其产物活跃的基因
体内废物处理机制的生理途径,包括参与清除的基因
单核吞噬细胞系统循环免疫复合物和凋亡细胞。第二个
组编码调节 T 和 B 淋巴细胞耐受和激活阈值的基因。
该项目是交互式 PPG 的一部分,旨在解决突变的总体假设
七个 SLAM 家族基因中的一个或多个影响有助于自身抗原耐受的途径
在人类和小鼠中。总的来说,我们对人类和小鼠的观察结果强烈支持
这
具体来说,我们将:
目标 1. 检验 SLAM-Family-locus {CD244<->Ly108} 控制 CD4 T 细胞和抗原的假设
展示 C57BL/6 小鼠的细胞功能。
目标 2.检验删除 {CD244<->Ly108} 基因组区间导致耐受性丧失的假设
C57BL/6 小鼠中的染色质。
目标 3.检验来自 129Sv 小鼠的 SLAM 家族基因有助于发育的假设
引入{CD244<->Ly108}-/-C57BL/6小鼠后狼疮的发生。
这些实验共同阐明了 APC、T 细胞和 B 细胞之间的相互作用,这些细胞受
SLAM-家族基因及其对小鼠狼疮易感性的控制。这些研究的结果应该
提出可应用于 SLE 患者的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CORNELIS P TERHORST其他文献
CORNELIS P TERHORST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CORNELIS P TERHORST', 18)}}的其他基金
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8296689 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
7560933 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
Role of SAP (SH2D1A) gene in T cell-dependent antibody response
SAP (SH2D1A) 基因在 T 细胞依赖性抗体反应中的作用
- 批准号:
7614096 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8102821 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
7882569 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
Primary Immuno-Deficiencies Affecting Specific Stages of the Immune Response
影响免疫反应特定阶段的原发性免疫缺陷
- 批准号:
8501241 - 财政年份:2009
- 资助金额:
$ 26.35万 - 项目类别:
SLAM Gene Family Controlled Pathways to SLE
SLAM 基因家族控制 SLE 通路
- 批准号:
7275918 - 财政年份:2006
- 资助金额:
$ 26.35万 - 项目类别: